| pubmed-article:19274675 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C0035366 | lld:lifeskim |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C0017296 | lld:lifeskim |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C0038661 | lld:lifeskim |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C1257975 | lld:lifeskim |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C0919437 | lld:lifeskim |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:19274675 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:19274675 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19274675 | pubmed:dateCreated | 2009-4-27 | lld:pubmed |
| pubmed-article:19274675 | pubmed:abstractText | Mesenchymal stem cells (MSCs) are a promising vehicle for targeted cancer gene therapy because of their potential of tumor tropism. For efficient therapeutic application, we developed retroviral vector-producing MSCs that enhance tumor transduction via progeny vector production. | lld:pubmed |
| pubmed-article:19274675 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19274675 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19274675 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19274675 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19274675 | pubmed:month | May | lld:pubmed |
| pubmed-article:19274675 | pubmed:issn | 1521-2254 | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:OzawaKeiyaK | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:UrabeMasashiM | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:ItoTakayukiT | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:MizukamiHiroa... | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:KumeAkihiroA | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:OkadaTakashiT | lld:pubmed |
| pubmed-article:19274675 | pubmed:author | pubmed-author:UchiboriRyosu... | lld:pubmed |
| pubmed-article:19274675 | pubmed:copyrightInfo | (c) 2009 John Wiley & Sons, Ltd. | lld:pubmed |
| pubmed-article:19274675 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19274675 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:19274675 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19274675 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19274675 | pubmed:pagination | 373-81 | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:meshHeading | pubmed-meshheading:19274675... | lld:pubmed |
| pubmed-article:19274675 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19274675 | pubmed:articleTitle | Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. | lld:pubmed |
| pubmed-article:19274675 | pubmed:affiliation | Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan. | lld:pubmed |
| pubmed-article:19274675 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19274675 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19274675 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19274675 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19274675 | lld:pubmed |
